Retirement Agreements in the Pharmaceuticals Industry
28 Contracts & Agreements
- BARR PHARMACEUTICALS INC (1 contract)
- BIODELIVERY SCIENCES INTERNATIONAL INC (3)
- Bristol-Myers Squibb (1)
- ENCYSIVE PHARMACEUTICALS INC (2)
- Endo International plc (1)
- Endo Pharmaceuticals Solutions Inc. (2)
- Lilly (Eli) & Co. (3)
- Mallinckrodt (1)
- Merck (5)
- Pacira Pharmaceuticals, Inc. (1)
- PENWEST PHARMACEUTICALS CO (1)
- Pfizer (2)
- Prestige Brands Holdings Inc (2)
- Supernus Pharmaceuticals, Inc. (1)
- TEVA PHARMACEUTICAL INDUSTRIES LTD (1)
- Zoetis (1)
- Transition and Retirement Agreement, dated September 20, 2023, between Pacira BioSciences, Inc. and David Stack (Pacira Pharmaceuticals, Inc., Filed With SEC on September 26, 2023)
- Bristol-Myers Squibb Company Benefit Equalization Plan Retirement Income Plan, effective as of January 1, 2012 and as amended and restated effective as of August 2, 2019 (Bristol-Myers Squibb, Filed With SEC on February 10, 2021)
- Retirement Agreement between Endo Health Solutions Inc. and Tony Pera, dated as of April 25, 2019 (Endo International plc, Filed With SEC on April 26, 2019)
- Form of Retirement Agreement, dated May 17, 2018, between the Company, the Retiring Directors and Broadfin Healthcare (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on May 17, 2018)
- Mallinckrodt Pharmaceuticals Supplemental Savings and Retirement Plan (Mallinckrodt, Filed With SEC on February 27, 2018)
- Teva Pharmaceuticals USA, Inc. Defined Contribution Supplemental Executive Retirement Plan (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on February 12, 2018)
- Retirement Agreement, dated January 12, 2018, by and between the Company and Vasisht (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on January 18, 2018)
- RETIREMENT AGREEMENT (BIODELIVERY SCIENCES INTERNATIONAL INC, Filed With SEC on December 18, 2015)
- RETIREMENT AGREEMENT (Prestige Brands Holdings Inc, Filed With SEC on May 14, 2015)
- PFIZER INC NONFUNDED SUPPLEMENTAL RETIREMENT PLAN (Zoetis, Filed With SEC on November 9, 2012)
- WYETH SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (amended and restated effective as of January 1, 2005) PURPOSE (Pfizer, Filed With SEC on February 28, 2012)
- PFIZER INC NONFUNDED SUPPLEMENTAL RETIREMENT PLAN (Pfizer, Filed With SEC on February 28, 2012)
- RETIREMENT AGREEMENT (Prestige Brands Holdings Inc, Filed With SEC on February 9, 2011)
- Confidential SUPERNUS PHARMACEUTICALS, INC. SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (Supernus Pharmaceuticals, Inc., Filed With SEC on December 23, 2010)
- EX-10.M: RETIREMENT BENEFITS EQUALIZATION PLAN (Merck, Filed With SEC on February 27, 2009)
- EX-10.L: SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (Merck, Filed With SEC on February 27, 2009)
- AMENDMENT TO EXECUTIVE RETIREMENT AGREEMENT (Endo Pharmaceuticals Solutions Inc., Filed With SEC on June 16, 2008)
- EXECUTIVE RETIREMENT AGREEMENT (Endo Pharmaceuticals Solutions Inc., Filed With SEC on March 7, 2008)
- EX-10.11: AMENDED AND RESTATED EXCESS SAVINGS AND RETIREMENT PLAN (BARR PHARMACEUTICALS INC, Filed With SEC on February 29, 2008)
- EX-10.L: SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (Merck, Filed With SEC on February 28, 2007)
- EX-10.L: RETIREMENT BENEFITS EQUALIZATION PLAN (Merck, Filed With SEC on February 28, 2006)
- Retirement Benefits Policy for Non-Employee Directors (ENCYSIVE PHARMACEUTICALS INC, Filed With SEC on January 31, 2006)
- Retirement Benefits Policy for Employees (ENCYSIVE PHARMACEUTICALS INC, Filed With SEC on January 31, 2006)
- Ex-10.2 Supplemental Executive Retirement Plan (PENWEST PHARMACEUTICALS CO, Filed With SEC on May 9, 2005)
- EX-10.L: RETIREMENT BENEFITS EQUALIZATION PLAN (Merck, Filed With SEC on March 9, 2005)
- Arrangement Regarding Retirement Benefits (Lilly (Eli) & Co., Filed With SEC on March 8, 2005)
- Letter concerning Retirement Benefits For Steven M. Paul (Lilly (Eli) & Co., Filed With SEC on March 8, 2005)
- Letter concerning Retirement Benefits for Charles E. Golden (Lilly (Eli) & Co., Filed With SEC on March 8, 2005)
